» Articles » PMID: 34572452

Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2

Overview
Journal Biomedicines
Date 2021 Sep 28
PMID 34572452
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The worldwide transmission of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a deadly or devastating disease is known to affect thousands of people every day, many of them dying all over the planet. The main reason for the massive effect of COVID-19 on society is its unpredictable spread, which does not allow for proper planning or management of this disease. Antibiotics, antivirals, and other prescription drugs, necessary and used in therapy, obviously have side effects (minor or significant) on the affected person, there are still not clear enough studies to elucidate their combined effect in this specific treatment, and existing protocols are sometimes unclear and uncertain. In contrast, it has been found that nutraceuticals, supplements, and various herbs can be effective in reducing the chances of SARS-CoV-2 infection, but also in alleviating COVID-19 symptoms. However, not enough specific details are yet available, and precise scientific studies to validate the approved benefits of natural food additives, probiotics, herbs, and nutraceuticals will need to be standardized according to current regulations. These alternative treatments may not have a direct effect on the virus or reduce the risk of infection with it, but these products certainly stimulate the human immune system so that the body is better prepared to fight the disease. This paper aims at a specialized literary foray precisely in the field of these "cures" that can provide real revelations in the therapy of coronavirus infection.

Citing Articles

Physiochemically and Genetically Engineered Bacteria: Instructive Design Principles and Diverse Applications.

Lin X, Jiao R, Cui H, Yan X, Zhang K Adv Sci (Weinh). 2024; 11(30):e2403156.

PMID: 38864372 PMC: 11321697. DOI: 10.1002/advs.202403156.


The Multisystem Impact of Long COVID: A Comprehensive Review.

Negrut N, Menegas G, Kampioti S, Bourelou M, Kopanyi F, Hassan F Diagnostics (Basel). 2024; 14(3).

PMID: 38337760 PMC: 10855167. DOI: 10.3390/diagnostics14030244.


Phytochemicals of as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery.

Ramli S, Wu Y, Batumalaie K, Guad R, Choy K, Kumar A Microorganisms. 2023; 11(4).

PMID: 37110423 PMC: 10142625. DOI: 10.3390/microorganisms11041000.


The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection.

Lu L, Gao Y, Quek S, Foster M, Eason C, Liu M Biomed Pharmacother. 2022; 154:113625.

PMID: 36058151 PMC: 9428603. DOI: 10.1016/j.biopha.2022.113625.


Novel and Alternative Therapeutic Strategies for Controlling Avian Viral Infectious Diseases: Focus on Infectious Bronchitis and Avian Influenza.

Abbas G, Yu J, Li G Front Vet Sci. 2022; 9:933274.

PMID: 35937298 PMC: 9353128. DOI: 10.3389/fvets.2022.933274.


References
1.
Sanchez-Sanchez M, Zepeda-Morales A, Carrera-Quintanar L, Viveros-Paredes J, Franco-Arroyo N, Godinez-Rubi M . Alliin, an Nutraceutical, ReducesMetaflammation Markers in DIO Mice. Nutrients. 2020; 12(3). PMC: 7146142. DOI: 10.3390/nu12030624. View

2.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021; 134:103-112. DOI: 10.1016/j.jclinepi.2021.02.003. View

3.
Ramdani L, Bachari K . Potential therapeutic effects of Resveratrol against SARS-CoV-2. Acta Virol. 2020; 64(3):276-280. DOI: 10.4149/av_2020_309. View

4.
Calder P, Carr A, Gombart A, Eggersdorfer M . Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients. 2020; 12(4). PMC: 7230749. DOI: 10.3390/nu12041181. View

5.
Panfili F, Roversi M, DArgenio P, Rossi P, Cappa M, Fintini D . Possible role of vitamin D in Covid-19 infection in pediatric population. J Endocrinol Invest. 2020; 44(1):27-35. PMC: 7299247. DOI: 10.1007/s40618-020-01327-0. View